Valeant Pharma may buy back up to $2 bln worth of securities
November 20, 2014 at 12:03 PM EST
Nov 20 (Reuters) - Canada's Valeant Pharmaceuticals International Inc said it may buy back up to $2 billion in senior notes, shares and other securities.
